December 18, 2014 1:13 AM ET

Biotechnology

Company Overview of Milestone Pharmaceuticals Inc.

Executive Profile

Philippe Douville Ph.D.

Chief Executive Officer and Director, Milestone Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Philippe Douville, Ph.D. serves as Chief Executive Officer of Milestone Pharmaceuticals, Inc. and served as its Chairman of the Board. Dr. Douville Co-founded and served as Chief Business Officer and Vice President of Genizon BioSciences Inc. He served as Director of Corporate Development of Algene Biotechnologies. He is a highly entrepreneurial executive with experience in research and the life sciences industry. He has 13 years experience in genetics and molecular ...

Corporate Headquarters

6100 Royalmount Avenue
Montreal, Quebec H4P 2R2

Canada

Phone: 514-496-3220
Fax: 514-496-3219

Board Members Memberships

Former Director
Chief Executive Officer and Director

Education

PhD 1991
McGill University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Milestone Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.